Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Clin Psychopharmacol. 1998 Apr;18(2):132-5.

Imipramine in the treatment of social phobia.

Author information

  • 1New York State Psychiatric Institute, Anxiety Disorders Clinic, NY 10032, USA.

Abstract

We report the results of an 8-week open trial of imipramine in 15 patients with social phobia. Nine patients completed the trial; six dropped out early because of adverse effects. The mean reduction in the Liebowitz Social Anxiety Scale was 15% and 18% for the intent-to-treat and completer groups, respectively; the overall response rate (based on the Clinical Global Impression Scale of 1 or 2, very much or much improved) was 20% (3/15) and 22% (2/9), respectively. The results from this open trial do not support the efficacy of imipramine as a treatment for social phobia.

PMID:
9555598
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk